Polaryx Therapeutics, Inc. PLYX Business Segments — General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Polaryx Therapeutics, Inc. 's business segments — general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Polaryx Therapeutics, Inc. 's business segments — general and administrative expense?
- Polaryx Therapeutics, Inc. (PLYX) reported business segments — general and administrative expense of $812K in Q1 2026.
- How has Polaryx Therapeutics, Inc. 's business segments — general and administrative expense changed year-over-year?
- Polaryx Therapeutics, Inc. 's business segments — general and administrative expense increased by 141.7% year-over-year, from $336K to $812K.
- What does business segments — general and administrative expense mean?
- This metric captures the overhead and administrative costs directly or indirectly allocated to the lysosomal storage disorders business segment. It includes personnel costs, legal fees, and facility expenses required to support the operational infrastructure of this specific therapeutic division. Tracking this helps evaluate the operational efficiency and management overhead associated with the segment's growth.